Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Jansen

Showing results (21-30 of 150) with videos related to

Pageof 15
Sort By:
Journal of Hepatology|June 27, 2006
Antiviral effect of peginterferon alfa-2b and alfa-2a comparedPeter L M Jansen, Henk W Reesink
Hepatology (Baltimore, Md.)|October 15, 2013
How sweet it is to activate FXRPeter L M Jansen, Frank G Schaap
Hepatology (Baltimore, Md.)|November 25, 2015
Pandora's box opens for cholestatic liver diseasePeter L M Jansen, Frank G Schaap
Journal of Hepatology|February 14, 2015
Pituitary TSH controls bile salt synthesisPeter L M Jansen, Frank G Schaap
Journal of Hepatology|February 9, 2012
Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinomaFlorie Borel, Pavlina Konstantinova, Peter L M Jansen
Scandinavian Journal of Gastroenterology. Supplement|November 1, 2002
Blockade of NF-kappaB activation and donation of nitric oxide: new treatment options in inflammatory bowel disease?G Dijkstra, H Moshage, P L M Jansen
FEBS Letters|February 19, 2019
The peroxisome biogenesis factors Pex3 and Pex19: multitasking proteins with disputed functionsRenate L M Jansen, Ida J van der Klei
Advanced Drug Delivery Reviews|January 22, 2003
Drug transport proteins in the liverKlaas Nico Faber, Michael Müller, Peter L M Jansen
Acta Neuropsychiatrica|March 12, 2016
Autism and autistic-like disorders: the hypothalamic-pituita-ry-adrenal system as a model for researchL M Jansen, C C Wied, H V Engeland
Nature Reviews. Gastroenterology & Hepatology|August 29, 2013
Bile acid receptors as targets for drug developmentFrank G Schaap, Michael Trauner, Peter L M Jansen
Pageof 15

Showing results (21-30 of 150) with videos related to

Sort By:
Pageof 15
Journal of Hepatology|June 27, 2006
Antiviral effect of peginterferon alfa-2b and alfa-2a comparedPeter L M Jansen, Henk W Reesink
Hepatology (Baltimore, Md.)|October 15, 2013
How sweet it is to activate FXRPeter L M Jansen, Frank G Schaap
Hepatology (Baltimore, Md.)|November 25, 2015
Pandora's box opens for cholestatic liver diseasePeter L M Jansen, Frank G Schaap
Journal of Hepatology|February 14, 2015
Pituitary TSH controls bile salt synthesisPeter L M Jansen, Frank G Schaap
Journal of Hepatology|February 9, 2012
Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinomaFlorie Borel, Pavlina Konstantinova, Peter L M Jansen
Scandinavian Journal of Gastroenterology. Supplement|November 1, 2002
Blockade of NF-kappaB activation and donation of nitric oxide: new treatment options in inflammatory bowel disease?G Dijkstra, H Moshage, P L M Jansen
FEBS Letters|February 19, 2019
The peroxisome biogenesis factors Pex3 and Pex19: multitasking proteins with disputed functionsRenate L M Jansen, Ida J van der Klei
Advanced Drug Delivery Reviews|January 22, 2003
Drug transport proteins in the liverKlaas Nico Faber, Michael Müller, Peter L M Jansen
Acta Neuropsychiatrica|March 12, 2016
Autism and autistic-like disorders: the hypothalamic-pituita-ry-adrenal system as a model for researchL M Jansen, C C Wied, H V Engeland
Nature Reviews. Gastroenterology & Hepatology|August 29, 2013
Bile acid receptors as targets for drug developmentFrank G Schaap, Michael Trauner, Peter L M Jansen
Pageof 15